Visum Pharma has been formed to develop therapeutics for diseases of great unmet need by leveraging novel insights into their pathogenesis. Our focus is to normalize the activity of key signaling nodes that, irrespective of precise causation or genetic underpinnings of the disease, represent tipping points in the disease process. To pursue these efforts, we have assembled a team with deep experience in neuroscience, early-stage biotech, and business development. Visum intends to develop programs that encompass large markets, unmet medical needs, and novel druggable solutions.
